A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer

Author： Park Se Nam Eunmi Bang Soo-Mee Cho Eun Shin Dong Lee Jae

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.62, Iss.1, 2008-06, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetic Angiogenesis Profiling for First-Line Chemotherapy in Patients With Advanced Gastric Cancer

By Dan Su Bai Li Li-Jie Wang Ting Zhang Zhi-Yuan Mao

Cancer Investigation, Vol. 31, Iss. 6, 2013-07 ,pp. : 390-396

Informa Healthcare

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T. Carlsson L. Einbeigi Z. Lidbrink E. Linderholm B. Lindh B. Loman N. Malmberg M. Rotstein S. Söderberg M. Sundquist M. Walz T. Hellström M. Svensson H. Åström G. Brandberg Y. Carstensen J. Fernö M. Bergh J.

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

By Moriwaki Toshikazu Hirai Shinji Hironaka Shuichi Amagai Kenji Soeda Atsuko Sato Mikio Nihei Takeshi Hirose Mitsuaki Matsuda Kenji Ohkawara Atsushi Yamaguchi Taketo Ozeki Mitsuharu Mamiya Takashi Murashita Tetsuya Hyodo Ichinosuke

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 354-361

Springer Publishing Company

Access to resources Recommend Favorite

Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer

By Choi In Lee Keun-Wook Kim Ki Kim Yu Kim Jee Lee Jong

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 992-997

Humana Press, Inc

Access to resources Recommend Favorite

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

By Banerjee S. Rustin G. Paul J. Williams C. Pledge S. Gabra H. Skailes G. Lamont A. Hindley A. Goss G. Gilby E. Hogg M. Harper P. Kipps E. Lewsley L-A Hall M. Vasey P. Kaye S. B.

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 679-687

Oxford University Press

Access to resources Recommend Favorite